Asthma is a serious chronic disease of the airways that affects approximately 14% of the population in the United States. The fundamental pathophysiologic component of asthma is airway narrowing, which causes airflow obstruction. Both inflammation and bronchoconstriction contribute to airway narrowing. The pathogenesis of airway inflammation in asthma and the natural history of the disease are the subject of intense research and study in many countries of the world. The mechanisms of airway inflammation are only partially understood but are the basis for the devastating symptoms that affect the quality of life of millions of people. Treatment of asthma is directed at decreasing airway inflammation to gain long-term control of the disease.
Pathophysiology| May 01 2000
Biologic Markers of Airway Inflammation in Asthma
Susan Janson, RN, DNSc, ANP, FAAN
From the School of Nursing, University of California, San Francisco, San Francisco, California.
Reprint requests to Susan Janson, RN, DNSc, ANP, FAAN, Department of Community Health Systems, School of Nursing, University of California, San Francisco, San Francisco, CA 94143-0608; e-mail: email@example.com
Search for other works by this author on:
AACN Adv Crit Care (2000) 11 (2): 232–240.
- Views Icon Views
- Share Icon Share
- Tools Icon Tools
- Search Site
Susan Janson; Biologic Markers of Airway Inflammation in Asthma. AACN Adv Crit Care 1 May 2000; 11 (2): 232–240. doi: https://doi.org/
Download citation file: